Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Mar 29,2016
RNA Bacteriophages May Open New Path to Fighting Antibiotic Resistant Infections
    Scientists at Washington University School of Medicine in St. Louis report that bacteriophages made of RNA likely play a much larger role in shaping the bacterial makeup of worldwide habitats than previously recognized. Their study ("Hyperexpansion of RNA Bacteriophage Diversity”), published in PLOS Biology, identified 122 new types of RNA bacteriophages in diverse ecological niches,Read more
More
RNA Bacteriophages May Open New Path to Fighting Antibiotic Resistant Infections
Mar 29,2016
Protein Consolidates Promoter Beachhead in Advance of Full Scale Transcription
    The expression of a gene may be likened to a seaborne invasion. Both are logistically complex operations that are hard to follow. Both involve arriving at the right landing site, establishing a beachhead, and only then staging a mechanized advance.     Beyond these generalities are transcriptional details that have been obscured by a biochemical fog ofRead more
More
Protein Consolidates Promoter Beachhead in Advance of Full Scale Transcription
Mar 28,2016
Devising an In Vitro Cell Surface Model
    Scientists have long been fascinated by the dichotomy that constitutes the cell surface: On one hand it is dynamically fluid, because it is dotted with diverse amounts of proteins, lipids, and carbohydrates. Yet the cell surface also acts as a stalwart rampart against the extracellular environment—setting up checkpoints that selectively allow entrance to molecules theRead more
More
Devising an In Vitro Cell Surface Model
Mar 28,2016
Genetically Modified Maggots Helps Wounds Heal Faster
    Researchers working with genetically engineered maggots have made an exciting discovery that could change how we treat wounds. The team, comprised of scientists from NC State and Massey University in New Zealand, has created a strain of green bottle fly (Lucilia sericata) larvae capable of producing a human growth factor in detectable amounts. This growthRead more
More
Genetically Modified Maggots Helps Wounds Heal Faster
Mar 25,2016
New Study Offers Insight into Extent of PKU Effect on Brain
    At birth, children are screened for an array of genetic diseases that may quickly present symptoms and be potentially life threatening. One such rare disorder is phenylketonuria (PKU), a metabolic condition in which the body cannot convert the amino acid phenylalanine into tyrosine, a precursor of dopamine and other important neurotransmitters. PKU is hallmarked byRead more
More
Mar 25,2016
RNA May Surpass DNA in Precision Medicine
    It's not an either/or situation. Both DNA sequencing and RNA sequencing hold clinical promise—diagnostically, prognostically, and therapeutically. It must be said, however, that RNA sequencing reflects the dynamic nature of gene expression, shifting with the vagaries of health and disease. Also, RNA sequencing captures more biochemical complexity, in the sense that it allows for theRead more
More
Mar 24,2016
Scientists Remove HIV from Human T Cells
    Scientists edited HIV-1 DNA out of the genome of human immune cells, preventing virus replication and reinfection of the cleared cells.     Using the CRISPR/Cas9 gene editing technique, scientists at Temple University eliminated HIV-1 DNA from T cell genomes in lab experiments, and prevented reinfection after the cells were re-exposed to the virus, they report inRead more
More
Mar 24,2016
New Biomarker Identified as Cause of Breast Cancer and Early Indicator
    Researchers at the Medical College of Georgia and Georgia Cancer Center within Augusta University have identified a gene, previously known for its role in DNA repair pathways, which they describe as being a cause of breast cancer. However, due the GT198 gene's newly identified role in carcinogenesis, it has a strong potential both as aRead more
More
Mar 23,2016
Dengue Vaccine Shows Promising Results in Clinical Trial
    The dengue virus is the most common mosquito-borne viral infection in the world, infecting nearly 400 million people annually. At its most severe, the flu-like disease can be fatal.  A clinical trial in which volunteers were infected with dengue virus 6 months after receiving either an experimental dengue vaccine developed by NIH scientists or aRead more
More
Mar 23,2016
Removing Epigenetic Post It Notes Returns Stem Cells to Unprimed State
    A drug originally intended to treat leukemia has an unexpected power. It can reverse stem cell development, converting primed pluripotent stem cells to naïve pluripotent stem cells. The drug, called MM-401, effectively removes epigenetic markers from histones, depriving the cell's DNA-reading machinery of indications of where to start reading. Stripped of its accumulated “Post-it notes,”Read more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->